Report Description

Forecast Period


Market Size (2022)

USD 12.36 Billion

CAGR (2023-2028)


Fastest Growing Segment

Test Kits

Largest Market

North America

Market Overview

Global Cholesterol Testing Market has valued at USD 12.36 Billion in 2022 and is anticipated to project robust growth in the forecast period with a CAGR of 6.92% through 2028. A cholesterol test, also referred to as a lipid profile or lipid panel, is a medical examination that evaluates the levels of different types of cholesterol and fats in your blood. It serves as a crucial diagnostic tool that provides valuable insights into your cardiovascular health. Monitoring and managing cholesterol levels can significantly contribute to the prevention of heart disease and the promotion of overall well-being. It is always advisable to consult with a healthcare professional to comprehend your test results and determine the most appropriate course of action based on your individual health requirements.

Key Market Drivers

Rising Prevalence of Cardiovascular Diseases

Cardiovascular diseases, including heart attacks and strokes, often have subtle or asymptomatic early stages. Cholesterol testing helps identify individuals with high cholesterol levels, who are at an increased risk of developing CVDs. Early detection allows for timely intervention and lifestyle changes that can help prevent or manage the progression of these diseases. Cholesterol testing provides valuable information for risk assessment and stratification. Individuals with elevated cholesterol levels are categorized as high-risk patients for CVDs. This categorization helps healthcare providers tailor treatment and management strategies, potentially preventing future cardiovascular events. For individuals diagnosed with CVDs or at risk of developing them, cholesterol testing is used to monitor the effectiveness of treatments such as medication, dietary changes, and exercise. Regular testing helps healthcare professionals adjust treatment plans as needed to achieve target cholesterol levels. The rising prevalence of cardiovascular diseases underscores the importance of cholesterol testing as a critical tool for prevention, early detection, and management. The increasing demand for cholesterol testing is a natural response to the need to address the growing burden of CVDs and their associated risk factors.

Increase in Demand of Point-of-Care Testing Devices and Home Cholesterol Testing Kits

Point-of-care testing devices and home cholesterol testing kits are playing a significant role in increasing the demand for cholesterol testing. Point-of-care testing devices and home testing kits provide the convenience of immediate testing without the need for a separate visit to a medical facility. This convenience encourages more frequent testing and monitoring, as individuals can easily check their cholesterol levels at home or at a nearby clinic. Rapid results from point-of-care testing and home kits allow individuals to receive immediate feedback on their cholesterol levels. This enables timely intervention, such as lifestyle adjustments or medication adherence, in case of elevated levels. Home testing kits empower individuals to take control of their health by monitoring their cholesterol levels regularly. This increased involvement in their healthcare encourages better management of risk factors and adherence to healthier lifestyles. Some individuals might be more comfortable conducting tests in the privacy of their own homes, which can lead to more accurate results due to reduced anxiety often associated with medical settings. For individuals with established cardiovascular conditions or who are at higher risk due to family history or other factors, point-of-care devices and home testing kits offer a convenient way to monitor their cholesterol levels regularly, supporting ongoing disease management.

Increasing Cases of Obesity

The increasing cases of obesity are a significant driver behind the rising demand for cholesterol testing. Obesity is closely linked to elevated cholesterol levels, especially high levels of LDL cholesterol (often referred to as "bad" cholesterol), which can contribute to the development of cardiovascular diseases (CVDs) and other health complications. Obesity is associated with changes in lipid metabolism, leading to higher levels of triglycerides and LDL cholesterol and lower levels of HDL cholesterol (often referred to as "good" cholesterol). Cholesterol testing helps identify individuals with unfavorable lipid profiles, prompting the need for lifestyle modifications or medical interventions. Obesity is a well-established risk factor for CVDs. Cholesterol testing serves as an essential tool for assessing an individual's cardiovascular risk. Healthcare providers often recommend cholesterol testing for obese individuals to determine their risk level and guide appropriate interventions. Regular cholesterol testing for individuals with obesity can help in the early detection of lipid abnormalities, allowing for timely interventions to prevent or manage cardiovascular risks. This proactive approach can lead to better health outcomes. Many individuals with obesity embark on weight loss and lifestyle modification journeys to improve their health. Cholesterol testing serves as a valuable marker to monitor the effects of these efforts on lipid levels, motivating individuals to stay on track and make necessary adjustments. Healthcare providers often emphasize the importance of cholesterol testing for individuals with obesity to educate them about their cardiovascular risks. This guidance encourages more people to undergo testing as part of their overall health management.

Rising Geriatric Population

The elderly population is more susceptible to cardiovascular diseases and other health issues, leading to a higher demand for cholesterol testing and monitoring among this demographic.  As individuals age, their bodies undergo various physiological changes that can impact cholesterol levels. Cholesterol tends to increase naturally with age, and this age-related dyslipidemia can elevate the risk of CVDs. Cholesterol testing becomes crucial for early detection and management of these changes. The elderly is at a greater risk of developing CVDs due to cumulative exposure to risk factors over time. Cholesterol testing helps identify individuals with elevated cholesterol levels, allowing for targeted interventions to manage these risks. Elderly individuals often have multiple chronic conditions, such as diabetes, hypertension, and obesity, which can further elevate their cardiovascular risk. Cholesterol testing assists in managing these complex health profiles. Many elderly individuals are on medications that can impact cholesterol levels, such as statins. Regular cholesterol testing helps healthcare providers monitor the effects of medications and adjust treatment plans as needed. Healthcare for the elderly often emphasizes preventive care to manage the risk of age-related health issues. Cholesterol testing plays a crucial role in identifying potential cardiovascular risks early and guiding preventive measures. For the elderly, lifestyle changes can significantly impact their health and quality of life. Cholesterol testing provides insights into the effectiveness of dietary modifications, exercise regimens, and other lifestyle interventions.